Cargando…

Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals

OBJECTIVE: To report various anatomic locations and clinical characteristics of pathologically proven myofibroblastoma in Koran patients. METHODS: Pathologic reports of patients who underwent surgeries at two centers between April 2003 and March 2016 were retrieved from the electronic medical record...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seul Ki, Lee, Ji Sun, Hong, Su Been, Lee, Jung Ryeol, Jee, Byung Chul, Suh, Chang Suk, Kim, Seok Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313367/
https://www.ncbi.nlm.nih.gov/pubmed/28217675
http://dx.doi.org/10.5468/ogs.2017.60.1.74
_version_ 1782508336899424256
author Kim, Seul Ki
Lee, Ji Sun
Hong, Su Been
Lee, Jung Ryeol
Jee, Byung Chul
Suh, Chang Suk
Kim, Seok Hyun
author_facet Kim, Seul Ki
Lee, Ji Sun
Hong, Su Been
Lee, Jung Ryeol
Jee, Byung Chul
Suh, Chang Suk
Kim, Seok Hyun
author_sort Kim, Seul Ki
collection PubMed
description OBJECTIVE: To report various anatomic locations and clinical characteristics of pathologically proven myofibroblastoma in Koran patients. METHODS: Pathologic reports of patients who underwent surgeries at two centers between April 2003 and March 2016 were retrieved from the electronic medical record system of the hospital. Pathologic reports were included after performing a search using the keyword “myofibroblastoma”. RESULTS: The cohort consisted of 11 subjects and included eight female and three male individuals. The patients' ages ranged from 9 to 66 years. Tumors were located in the vagina in three patients and presented in the breast in seven patients. One case presented with an abdominal mass. The tumors ranged in mean size from 4.0 to 53.0 mm. Despite a relatively long-term follow-up, no case had evidence of tumor recurrence. CONCLUSION: We evaluated the various anatomic locations of pathologically proven myofibroblastoma in Korean patients. As an extremely rare tumor, physicians should pay special attention to differential diagnosis. Surgical resection is the preferred method for a cure, and the recurrence rate is extremely low.
format Online
Article
Text
id pubmed-5313367
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society
record_format MEDLINE/PubMed
spelling pubmed-53133672017-02-18 Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals Kim, Seul Ki Lee, Ji Sun Hong, Su Been Lee, Jung Ryeol Jee, Byung Chul Suh, Chang Suk Kim, Seok Hyun Obstet Gynecol Sci Original Article OBJECTIVE: To report various anatomic locations and clinical characteristics of pathologically proven myofibroblastoma in Koran patients. METHODS: Pathologic reports of patients who underwent surgeries at two centers between April 2003 and March 2016 were retrieved from the electronic medical record system of the hospital. Pathologic reports were included after performing a search using the keyword “myofibroblastoma”. RESULTS: The cohort consisted of 11 subjects and included eight female and three male individuals. The patients' ages ranged from 9 to 66 years. Tumors were located in the vagina in three patients and presented in the breast in seven patients. One case presented with an abdominal mass. The tumors ranged in mean size from 4.0 to 53.0 mm. Despite a relatively long-term follow-up, no case had evidence of tumor recurrence. CONCLUSION: We evaluated the various anatomic locations of pathologically proven myofibroblastoma in Korean patients. As an extremely rare tumor, physicians should pay special attention to differential diagnosis. Surgical resection is the preferred method for a cure, and the recurrence rate is extremely low. Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2017-01 2017-01-19 /pmc/articles/PMC5313367/ /pubmed/28217675 http://dx.doi.org/10.5468/ogs.2017.60.1.74 Text en Copyright © 2017 Korean Society of Obstetrics and Gynecology http://creativecommons.org/licenses/by-nc/3.0/ Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Seul Ki
Lee, Ji Sun
Hong, Su Been
Lee, Jung Ryeol
Jee, Byung Chul
Suh, Chang Suk
Kim, Seok Hyun
Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals
title Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals
title_full Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals
title_fullStr Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals
title_full_unstemmed Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals
title_short Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals
title_sort clinicopathologic evaluation of myofibroblastoma: a study in two hospitals
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313367/
https://www.ncbi.nlm.nih.gov/pubmed/28217675
http://dx.doi.org/10.5468/ogs.2017.60.1.74
work_keys_str_mv AT kimseulki clinicopathologicevaluationofmyofibroblastomaastudyintwohospitals
AT leejisun clinicopathologicevaluationofmyofibroblastomaastudyintwohospitals
AT hongsubeen clinicopathologicevaluationofmyofibroblastomaastudyintwohospitals
AT leejungryeol clinicopathologicevaluationofmyofibroblastomaastudyintwohospitals
AT jeebyungchul clinicopathologicevaluationofmyofibroblastomaastudyintwohospitals
AT suhchangsuk clinicopathologicevaluationofmyofibroblastomaastudyintwohospitals
AT kimseokhyun clinicopathologicevaluationofmyofibroblastomaastudyintwohospitals